Evidence map›Paper›PMID 32819429›Full record

ArticleTrials2020

The effect of on-site CT-derived fractional flow reserve on the management of decision making for patients with stable chest pain (TARGET trial): objective, rationale, and design.

Junjie Yang, Dongkai Shan, Mei Dong, Zhiqiang Wang, Xiang Ma, Xinyang Hu, Hesong Zeng, Yundai Chen

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03901326 (The Effect of On-site CT-derived Fractional Flow Reserve on the Management Making for the Patients With Stable Chest Pain), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03901326 nacompletednot on this map

The Effect of On-site CT-derived Fractional Flow Reserve on the Management Making for the Patients With Stable Chest Pain (TARGET Trial)

TypeinterventionalSponsorChinese PLA General HospitalRan2019 to 2022Enrolled1,216ConditionsCoronary Artery DiseaseArmsCT-FFR assessment
3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Junjie YangDepartment of Cardiology, Chinese PLA General Hospital, 28 Fuxing Rd, Haidian District, Beijing, 100853, People's Republic of China.
Dongkai ShanDepartment of Cardiology, Chinese PLA General Hospital, 28 Fuxing Rd, Haidian District, Beijing, 100853, People's Republic of China.
Mei DongDepartment of Cardiology, Qilu Hospital of Shandong University, Jinan, People's Republic of China.
Zhiqiang WangDepartment of Cardiology, Anzhen Hospital, Capital Medical University, Beijing, People's Republic of China.
Xiang MaDepartment of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumchi, People's Republic of China.
Xinyang HuDepartment of Cardiology, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China.
Hesong ZengDepartment of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Yundai ChenDepartment of Cardiology, Chinese PLA General Hospital, 28 Fuxing Rd, Haidian District, Beijing, 100853, People's Republic of China. cyundai@vip.163.com.

Funding

Beijing Nova Program Z181100006218055National Key Research and Development program of China (CN) 2016YFC1300304
6 · The paper itself

Abstract

backgroundThe diagnostic accuracy of CT-derived fractional flow reserve (CT-FFR) in clinical application has been well validated. This advanced technology focus on evaluating anatomical stenosis and functional ischemia simultaneously. However, the effect of CT-FFR on the management of decision making has not been fully evaluated in randomized controlled design. METHOD/

designTARGET study is a pragmatic, multicenter, prospective, open-label, and randomized controlled trial evaluating the effect of a CCTA/CT-FFR strategy (group A) versus usual care (group B) on intermediate-to-high risk patients with suspected CAD who undergo clinically indicated diagnostic evaluation. A total sample size of 1216 subjects will be enrolled and followed up for 12 months. This study will be performed in 6 Chinese hospitals, and the primary endpoint is the planned ICA without significant obstructive CAD within 90 days. The secondary endpoints include MACE, quality of life, medical expenditure, and cumulative radiation exposure during 1-year follow-up. DISCUSSION: The study will provide information to patients, health care providers, and other stakeholders in China about which strategy could be more effective in the management of intermediate-to-high risk patients with suspect CAD.

trial registrationClinicalTrials.gov NCT03901326 . Registered on 3 April 2019.

Indexed as

Clinical Decision-MakingFractional Flow Reserve, MyocardialTomography, X-Ray ComputedArtificial IntelligenceChest PainChinaCoronary AngiographyCoronary Artery DiseaseCoronary StenosisCross-Sectional StudiesHemodynamicsHumansMulticenter Studies as TopicPercutaneous Coronary InterventionPragmatic Clinical Trials as TopicProspective StudiesCoronary artery diseaseCoronary computed tomographic angiographyFractional flow reserveManagementNon-invasive test

Identifiers

PMID32819429
PMCPMC7439553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.